» Articles » PMID: 35008448

Metabolic Therapy of Heart Failure: Is There a Future for B Vitamins?

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jan 11
PMID 35008448
Authors
Affiliations
Soon will be listed here.
Abstract

Heart failure (HF) is a plague of the aging population in industrialized countries that continues to cause many deaths despite intensive research into more effective treatments. Although the therapeutic arsenal to face heart failure has been expanding, the relatively short life expectancy of HF patients is pushing towards novel therapeutic strategies. Heart failure is associated with drastic metabolic disorders, including severe myocardial mitochondrial dysfunction and systemic nutrient deprivation secondary to severe cardiac dysfunction. To date, no effective therapy has been developed to restore the cardiac energy metabolism of the failing myocardium, mainly due to the metabolic complexity and intertwining of the involved processes. Recent years have witnessed a growing scientific interest in natural molecules that play a pivotal role in energy metabolism with promising therapeutic effects against heart failure. Among these molecules, B vitamins are a class of water soluble vitamins that are directly involved in energy metabolism and are of particular interest since they are intimately linked to energy metabolism and HF patients are often B vitamin deficient. This review aims at assessing the value of B vitamin supplementation in the treatment of heart failure.

Citing Articles

Short-Chain Fatty Acids and Their Metabolic Interactions in Heart Failure.

Chulenbayeva L, Issilbayeva A, Sailybayeva A, Bekbossynova M, Kozhakhmetov S, Kushugulova A Biomedicines. 2025; 13(2).

PMID: 40002756 PMC: 11853371. DOI: 10.3390/biomedicines13020343.


Effects of E-Cigarettes on the Lung and Systemic Metabolome in People with HIV.

Zaparte A, Christopher C, Arnold C, Richey L, Castille A, Mistretta K Metabolites. 2024; 14(8).

PMID: 39195530 PMC: 11356516. DOI: 10.3390/metabo14080434.


2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis.

Peng F, Liao M, Jin W, Liu W, Li Z, Fan Z Signal Transduct Target Ther. 2024; 9(1):133.

PMID: 38744811 PMC: 11094072. DOI: 10.1038/s41392-024-01816-1.


Association between Variation in Body Fat Mass Magnitude and Intake of Nutrients, including Carbohydrates, Fat, and B Vitamins, in a Cohort of Highly Trained Female Athletes.

Baranauskas M, Kupciunaite I, Lieponiene J, Stukas R Foods. 2023; 12(22).

PMID: 38002209 PMC: 10670790. DOI: 10.3390/foods12224152.


Metabolic Remodeling during Early Cardiac Lineage Specification of Pluripotent Stem Cells.

Bobori S, Zhu Y, Saarinen A, Liuzzo A, Folmes C Metabolites. 2023; 13(10).

PMID: 37887411 PMC: 10608731. DOI: 10.3390/metabo13101086.


References
1.
Bonen A, Heynen M, Hatta H . Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle. Appl Physiol Nutr Metab. 2006; 31(1):31-9. DOI: 10.1139/h05-002. View

2.
Taegtmeyer H . Metabolism--the lost child of cardiology. J Am Coll Cardiol. 2000; 36(4):1386-8. DOI: 10.1016/s0735-1097(00)00870-6. View

3.
Uzelac J, Djukic T, Radic T, Mutavdzin S, Stankovic S, Rakocevic J . Folic acid affects cardiometabolic, oxidative stress, and immunohistochemical parameters in monocrotaline-induced rat heart failure. Can J Physiol Pharmacol. 2020; 98(10):708-716. DOI: 10.1139/cjpp-2020-0030. View

4.
Quadros E . Advances in the understanding of cobalamin assimilation and metabolism. Br J Haematol. 2009; 148(2):195-204. PMC: 2809139. DOI: 10.1111/j.1365-2141.2009.07937.x. View

5.
Ahmed L, Hassan O, Galal O, Mansour D, El-Khatib A . Beneficial effects of benfotiamine, a NADPH oxidase inhibitor, in isoproterenol-induced myocardial infarction in rats. PLoS One. 2020; 15(5):e0232413. PMC: 7209119. DOI: 10.1371/journal.pone.0232413. View